Participate in Research

Browse Clinical Trials
Study for Patients with HIT in the Buffalo General ICU
Protocol: STUDY00007570
Full Title
Use of Thromboelastography (TEG) as Point of Care (POC) Testing for Heparin-Induced Thrombocytopenia (HIT)
Description
The University at Buffalo (UB) School of Pharmacy and Pharmaceutical Sciences is conducting a study for patients currently admitted to the Buffalo General Intensive Care Unit (ICU). The goal of the study is to see if a new blood test may be able to identify the condition known as “Heparin-Induced Thrombocytopenia” (or “HIT”) that can be potentially fatal and cause blood clots to form in the legs, lungs, or lead to heart attack or stroke.
Compensation: No
Eligibility
Adults 18 years or older Patients in the Buffalo General Intensive Care Unit who are suspected to have heparin-induced thrombocytopenia (HIT)
Age Group: Adults
Principal Investigator: Maya Holsen
Contact(s)
Maya Holsen
mayahols@buffalo.edu

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions
Study Team Login